Bobo-Dioulasso | Ouagadougou | Fianarantsoa | Kumasi | |
---|---|---|---|---|
n/N (%) | n/N (%) | n/N (%) | n/N (%) | |
Crude seropositivity | 317 / 627 (50·6)f1 | 170 / 522 (32·6)f2 | 253 / 674 (37·5)f3 | 131 / 340 (38·8)f4 |
No test for acute infection performed since onset of pandemic | 611 / 627 (97·4) | 493 / 522 (94·4) | 655 / 674 (97·2) | 322 / 340 (94·7) |
Test for acute infection performed prior to survey | 16 / 627 (2·6) | 29 / 522 (5·6) | 19 / 674 (2·8) | 18/340 (5·3) |
Positive results for acute infection among those tested | 2 / 16 (12·5) | 1 / 29 (3·5) | 4 / 19 (21·1) | 2/18 (11·1) |